Back |
home / stock / alzn / alzn message board
Subject | By | Source | When |
---|---|---|---|
It's Alive!!!!!! | Avidfisher | investorshub | 04/12/2022 9:53:22 PM |
here we are in the doldrums along with | PennyStockTrader2 | investorshub | 04/06/2022 4:49:09 PM |
Train wreck!!!!!! | Roozy | investorshub | 04/05/2022 8:03:03 PM |
Pipeline...https://alzamend.com/pipeline/ | beambe | investorshub | 03/22/2022 5:26:23 PM |
good Volume | beambe | investorshub | 03/22/2022 4:30:49 PM |
Mark Gustafson? Director? | Roozy | investorshub | 03/16/2022 7:11:15 PM |
How low can you go? | Roozy | investorshub | 03/16/2022 1:46:52 AM |
So true! So far a 1 trick pony | Roozy | investorshub | 03/14/2022 8:13:44 PM |
ouch...where's the news, PRs, updates.....?? | zagdad | investorshub | 03/14/2022 5:16:36 PM |
$33 to .98 what am I missing? | Roozy | investorshub | 03/11/2022 9:37:46 PM |
I cant predict the future, nobody can. I | PennyStockTrader2 | investorshub | 01/31/2022 10:36:40 PM |
You're funny. So you don't wish you sold | eqinvestor | investorshub | 01/31/2022 10:28:41 PM |
znewcar1: ALZN 28% v57M c3.08 f88,8M H gap up dipped a little to 2.48 then had trouble pushing throu | znewcar1 | investorshangout | 12/15/2021 2:34:20 AM |
Chasing Stars: ALZN Stock Chart Video Analysis 12-07-2021 Alzamend Neuro Inc. $ALZN Today we take a | Chasing Stars | investorshangout | 12/07/2021 11:08:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Alzamend Neuro Inc. Company Name:
ALZN Stock Symbol:
NASDAQ Market:
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical compa...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...